Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$27.52 - $37.99 $11,448 - $15,803
-416 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$30.71 - $45.71 $12,775 - $19,015
416 New
416 $13,000
Q2 2021

Aug 12, 2021

SELL
$54.88 - $79.29 $32,214 - $46,543
-587 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$70.65 - $96.76 $41,471 - $56,798
587 New
587 $43,000
Q2 2020

Aug 13, 2020

SELL
$25.95 - $43.15 $13,831 - $22,998
-533 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$26.15 - $77.24 $13,937 - $41,168
533 New
533 $15,000
Q4 2019

Feb 10, 2020

SELL
$60.18 - $154.77 $46,398 - $119,327
-771 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$140.29 - $189.96 $108,163 - $146,459
771 New
771 $108,000
Q4 2018

Feb 13, 2019

SELL
$81.94 - $139.71 $15,650 - $26,684
-191 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$138.11 - $169.04 $26,379 - $32,286
191 New
191 $26,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.